Abstract
Neuroinflammation plays important roles in neuronal cell death and functional deficits after TBI. Small conductance Ca2+-activated K+ channels (SK) have been shown to be potential therapeutic targets for treatment of neurological disorders, such as stroke and Parkinson’s disease (PD). The aim of the present study was to investigate the role of SK channels in an animal model of TBI induced by controlled cortical impact (CCI). The SK channels activator NS309 at a concentration of 2 mg/kg was administered by intraperitoneal injection, and no obviously organ-related toxicity of NS309 was found in Sprague-Dawley (SD) rats. Treatment with NS309 significantly reduced brain edema after TBI, but had no effect on contusion volume. This protection can be observed even when the administration was delayed by 4 h after injury. NS309 attenuated the TBI-induced deficits in neurological function, which was accompanied by the reduced neuronal apoptosis. The results of immunohistochemistry showed that NS309 decreased the number of neutrophils, lymphocytes, and microglia cells, with no effect on astrocytes. In addition, NS309 markedly decreased the levels of pro-inflammatory cytokines (IL-1β, IL-6 and TNF-α) and chemokines (MCP-1, MIP-2, and RANTES), but increased the levels of anti-inflammatory cytokines (IL-4, IL-10, and TGF-β1) after TBI. The results of RT-PCR and western blot showed that NS309 increased TSG-6 expression and inhibited NF-κB activation. Furthermore, knockdown of TSG-6 using in vivo transfection with TSG-6 specific shRNA partially reversed the protective and anti-inflammatory effects of NS309 against TBI. In summary, our results indicate that the SK channel activator NS309 could modulate inflammation-associated immune cells and cytokines via regulating the TSG-6/NF-κB pathway after TBI. The present study offers a new sight into the mechanisms responsible for SK channels activation with implications for the treatment of TBI.
Highlights
Traumatic brain injury (TBI) is defined as damage to the brain resulting from external mechanical force, which is usually caused by vehicle crashes, falls, or physical abuse (Cornelius, 2013)
We investigated the therapeutic potential of Small conductance K+ (SK) channel activation using NS309 against the TBI-induced neuronal injury, cell death cascades, and neurological dysfunction, and investigated the potential underlying mechanisms with focus on neuroinflammation
The results showed that TBI caused a significant increase in brain water content, which was partially prevented by NS309 pretreatment
Summary
Traumatic brain injury (TBI) is defined as damage to the brain resulting from external mechanical force, which is usually caused by vehicle crashes, falls, or physical abuse (Cornelius, 2013). Despite the dramatic improvements in the management of TBI, to date there is no effective pharmacological treatment available to patients, and it remains one of the leading causes of death and disability in children and young adults. In recent years, increasing evidence has indicated that among various long-lasting pathological changes induced by secondary damage after TBI, neuroinflammation played important roles in neuronal cell death and functional deficits (Corps et al, 2015). Finding treatments that aim at minimizing secondary injury by modifying inflammatory response becomes a critical strategy for TBI patients, and some anti-inflammatory agents targeting neuroglia cells activation or inflammatory cytokines have been proved to exert protective effects in both in vitro and in vivo experiments (Shohami, 1997; Lynch, 2005; Chen, 2011)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
